-
October 30, 2026
A coalition of 23 states and the District of Columbia urged a Rhode Island federal court Friday to let them continue challenging a now-rescinded Trump administration directive to "temporarily" withhold their federal funding, arguing a permanent injunction should still be on the table.
-
October 30, 2026
On Tuesday, voters in Massachusetts and Idaho will consider ballot measures that would roll back or restrict marijuana legalization, marking the first time that all statewide ballot questions on the issue of cannabis are geared toward fighting reform.
-
October 30, 2026
The U.S. Drug Enforcement Administration began registration of more than 900 state-licensed medical marijuana dispensaries across seven states, according to an announcement on Friday by the U.S. Department of Justice, which said applications for manufacturers and distributors would likely require additional review.
-
October 30, 2026
Pharmaceutical ingredient manufacturer Pfanstiehl Holdings Inc. has sued a minority shareholder and its general partner in the Delaware Chancery Court, seeking to unwind a $52.3 million transaction that allegedly transferred a majority economic interest in the shareholder's stake to an unidentified investor without required notice or consent.
-
October 30, 2026
A coalition of 48 states and territories is asking a Connecticut federal judge to give his final approval to a $29.6 million settlement with Glenmark Pharmaceuticals Ltd. that would end claims that the drugmaker conspired with competitors to inflate prices and allocate markets for generic drugs.
-
October 30, 2026
An Ohio state judge permanently blocked provisions of the state's "heartbeat law" that were previously under review after the court found that the bill's main feature — its prohibition on abortion after around six weeks of pregnancy — violated the state's constitution.
-
October 30, 2026
Two biotechnology firms began trading on Friday after raising a combined $310 million in their initial public offerings, marking the latest in a wave of biotechs to hit the public markets.
-
October 30, 2026
The Federal Circuit Friday overturned a $9.1 million attorney fee award issued to Elysium Health Inc. stemming from a patent infringement case brought by ChromaDex and Dartmouth College, ruling that a district judge had not gone far enough in his patent eligibility analysis.
-
October 30, 2026
The Centers for Medicare & Medicaid Services can't subject AbbVie's Botox to Medicare price negotiations under the Inflation Reduction Act, a D.C. federal judge held, finding CMS misinterpreted an IRA exclusion concerning biological products derived from human plasma.
-
October 30, 2026
Pierce Atwood LLP failed to win dismissal of a lawsuit from a Ukrainian oligarch who says the firm's advice led to a $1.85 million judgment against him in investor litigation over the liquidation of now-insolvent genetic testing company Pathway Genomics Corp.
-
October 29, 2026
A California federal judge said Thursday that he'll give final approval to a $59.5 million settlement resolving class claims over a menstrual tracking app sharing sensitive health data with Google, but he cut the $19 million attorney fee request by 5%, saying counsel is "taking money out of consumers' pockets."
-
October 29, 2026
The Colorado Supreme Court declined Thursday to take up transgender youth patients' challenge to a Denver judge's ruling that discharged their contempt citation against Children's Hospital Colorado for not resuming providing medical gender-affirming care to transgender adolescents.
-
October 29, 2026
A national fertility clinic network has been hit with a suit in Los Angeles Superior Court alleging it jeopardized a 50-year-old woman's ability to have a biological child by transporting her frozen eggs across state lines to an automated facility without her permission.
-
October 29, 2026
Plaintiffs in massive multidistrict litigation over toxic water at the Camp Lejeune military base are urging a North Carolina federal court to reject the federal government's bid for a Lone Pine motion requiring claimants to submit proof of their claims, saying it would delay the litigation by years, if not decades, and cause the plaintiffs' costs to skyrocket.
-
October 29, 2026
The Delaware Chancery Court has ruled that private equity firm TowerBrook Capital Partners LP and health system Ascension Health Alliance must face a stockholder claim challenging healthcare revenue management venture R1 RCM Inc.'s $8.9 billion take-private deal, finding that their joint investment vehicle qualified as a controlling stockholder despite owning less than one-third of the company's voting shares.
-
October 29, 2026
The U.S. Department of Labor's employee benefits arm unveiled a final rule Thursday that requires pharmacy benefit managers — which act as intermediaries between drugmakers, pharmacies and insurers — to make new disclosures on their fees and compensation to employer-sponsored group health plans.
-
October 28, 2026
Over the summer and early fall, lawmakers proposed measures aimed at putting safeguards around the rapidly growing industry of artificial intelligence, as public concerns over its safety climb in tandem. The new nominee to head the U.S. Food and Drug Administration also faced sharp queries over her views on vaccines and birth control.
-
October 28, 2026
Transgender youth patients of Children's Hospital Colorado are challenging a judge's discharge of their contempt citation against the hospital for not resuming the provision of medical gender-affirming care to them, urging Colorado's justices to decide whether the hospital complied with an injunction prohibiting it from refusing to provide the care.
-
October 28, 2026
The head of the U.S. Patent and Trademark Office has turned down Pogona LLC's argument that Merck's challenge to a patent on selecting a type of bacteria to use in a vaccine against pneumococcal disease was an "abusive" attack on the patent.
-
October 28, 2026
Boehringer Ingelheim USA Corp. and workers who accused the pharmaceutical company of misusing forfeitures from an employee 401(k) plan have settled their federal benefits dispute, parties told a Connecticut federal court Wednesday.
-
October 28, 2026
Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly sought to thwart competition for its single-use insulin injector pen.
-
October 28, 2026
Bristol-Myers Squibb Co. and its subsidiary Celgene Corp. urged the Second Circuit to uphold the dismissal of health plans' proposed antitrust class action alleging that the drugmaker fraudulently obtained patents for the cancer drug Pomalyst, saying it properly disclosed materials to the patent office and filed valid patent infringement lawsuits against generic-drug makers.
-
October 28, 2026
A Fourth Circuit judge on Wednesday sharply questioned the attorney for a physician challenging North Carolina restrictions on the abortion medication mifepristone, citing case law he said treats federal rules as a "floor and not a ceiling" on what states can require.
-
October 27, 2026
A group of Massachusetts hospitals claim drugmaker Eli Lilly & Co. unlawfully holds hostage medication discounts meant to benefit low-income patients by demanding that hospitals hand over sensitive patient claims data or pay "exorbitant" inflated prices, according to a lawsuit filed Tuesday in Boston federal court.
-
October 27, 2026
A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are among the arguments the Federal Circuit will hear in November.